[Skip to Content]
[Skip to Content Landing]
March 24, 1956


JAMA. 1956;160(12):1091. doi:10.1001/jama.1956.02960470087024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  I read with interest the editorial on anthrax that appeared in the Jan. 7, 1956, issue of The Journal, page 52. I wish to point out that pulmonary anthrax usually results in the expectoration of thick mucus, from which anthrax bacilli can be recovered with ease. Unfortunately, my patient, as cited in the editorial, was the exception, and the bacteriological diagnosis was delayed; however, nasopharyngeal smears demonstrated the presence of anthrax. Also, sulfathiazole is no longer the drug of choice, as stated in the editorial; it was used by me from 1939 to 1947. Penicillin and the broad-spectrum antibiotics are now used exclusively in the treatment of anthrax. After the advent of penicillin, American pharmaceutical houses ceased to manufacture antianthrax serum, which is no longer available commercially.

First Page Preview View Large
First page PDF preview
First page PDF preview